Certified French language Translation of Reasons for Order and Order rendered on 07-DEC-2010 by The Honourable Madam Justice Heneghan filed on 29-MAY-2018 pursuant to s. 20 of the Official Languages Act. Copy of Translation of Reasons for Order and Order entered in J. & O. Book, volume 1370 page(s) 492 - 500

Copy of Notice of Appeal (Appeal Court File No. A-22-10 ) appealing the Order of the Honourable Justice Heneghan dated December 18, 2009. filed in the Court of Appeal on 22-APR-2010 on behalf of Appellant placed on file on 08-JUN-2011

Copy of Amended Notice of Appeal on behalf of Respondent placed on file on 27-APR-2010 Original filed on Court File No. A-22-10

Reasons for Order and Order dated 07-DEC-2010 rendered by The Honourable Madam Justice Heneghan Matter considered with personal appearance The Court's decision is with regard to Motion Doc. No. 28 Result: dismissed "THIS COURT ORDERS that the motion for directions is dismissed with costs to Pharmascience in accordance with paragraph 24 above." Filed on 07-DEC-2010 certified copies sent to parties Transmittal Letters placed on file. Interlocutory Decision Copy of Reasons for Order and Order entered in J. & O. Book, volume 1108 page(s) 60 - 69

Communication to the Court from the Registry dated 21-OCT-2010 re: Motions being heard on October 25, 2010 in T-124-08 and T-2221-07

Ottawa 25-OCT-2010 BEFORE The Honourable Madam Justice Heneghan Language: E Before the Court: Motion Doc. No. 28 on behalf of Applicant seeking special directions regarding costs pursuant to Rule 403. Result of Hearing: Matter reserved held in Court Senior Usher: L. Chamberland Duration per day: 25-OCT-2010 from 09:30 to 11:10 Courtroom : Conference Room 1104, 11th Floor - Thomas D'Arcy McGee Bldg. - Ottawa Court Registrar: Christen Clement Total Duration: 1h40min Appearances: Brian Daley/Kavita Ramamoorthy 514-847-4746 representing Applicant Carol Hitchman 416-865-8259 representing Respondent Comments: Three further motions were heard in T-124-08 immediately following this matter. Minutes of Hearing entered in Vol. 832 page(s) 75 - 81 Abstract of Hearing placed on file

Covering letter from Respondent - Pharmascience Inc. dated 21-OCT-2010 concerning Supplemental Book of Authorities and Solicitor's Certificate of Service placed on file on 21-OCT-2010

Solicitor's certificate of service on behalf of Carol Hitchman confirming service of Supplementary Book of Authorities of the Responding Party (Pharmascience) upon Applicants and Respondent (Minister of Health) by electronic courier on 21-OCT-2010 filed on 21-OCT-2010

Supplementary Book of Authorities consisting of 3 volume(s) on behalf of Respondent - Pharmascience Inc. with proof of service upon Applicants on 21-OCT-2010 received on 21-OCT-2010

Copy of written direction of Madam Heneghan dated 01-SEP-2010 placed on file on 01-SEP-2010 Original placed on Court File No. T-124-08

Written directions received from the Court: The Honourable Madam Justice Heneghan dated 01-SEP-2010 directing that "...I note that the Attorney General will not be participating in the hearing of Pfizer's motion. I confirm that the motion will be heard in Ottawa on October 25, 2010...I propose that the hearing of the motion in the within file proceed immediately after the hearing of the motions in cause number T-124-08. Counsel are invited to advise the Registry if they have other views. This Direction will be filed in T-2221-07 and placed on the file in T-124-08." placed on file on 01-SEP-2010 Confirmed in writing to the party(ies)

Letter from Applicant dated 24-AUG-2010 "...We are available on October 25, 2010 in Ottawa for a hearing in respect of the Applicants' motions seeking a special direction for costs...We respectfully propose the following schedule for perfection of Apotex's motion:..." (scanned to Justice Heneghan) received on 24-AUG-2010

Letter from Respondent - The Attorney General of Canada dated 18-AUG-2010 "Further to the Directive of Madam Justice Heneghan on August 16, 2010, this letter is to inform the Court that the Respodent, the Attorney General of Canada, on behalf of the Minister of Health, will have no representations and therefore will not be present for the upcoming hearing of motions with respect to cost to be scheduled for October 2010 in abovementioned file." received on 18-AUG-2010

Letter from Respondent - Pharmascience Inc. dated 17-AUG-2010 "This letter follows the Direction of Madam Justice Henaghan dated August 16, 2010. We are available in Toronto on October 21, 2010 or in Ottawa on October 25, 26 or 27, 2010 for a hearing of the Applicants' motion seeking a Special Direction with respect to cost." received on 17-AUG-2010

Oral directions received from the Court: The Honourable Madam Justice Heneghan dated 16-AUG-2010 directing that "I have read the letter dated August 12, 2010 from counsel for the Applicants in this mattter. In light of the fact that there is a motion outsdanding in related file T-124-08 with respect to cost, it seems to me that both motion should be heard more or less at the same time. In my opinion, it is more convenient to deal with these matters by an oral hearing, either in person or by video conference. In that regard, I ask Counsel for the parties to advise as of their availability in Toronto on October 21st or October 22nd or in Ottawa during the week of October 25th. This Direction will be filed on T-2221-07 and placed on T-124-08." placed on file on 16-AUG-2010 Confirmed in writing to the party(ies)

Letter from Applicants dated 12-AUG-2010 to inquire as to the status of the Applicants' Motion in Writing filed May 18, 2010 seeking a Special Direction regarding costs pursuant to Rule 403 received on 12-AUG-2010

Letter from Applicant dated 15-JUN-2010 Writing in response to June 8th letter from Pharmascience. Applicants disagree with Pharmascience's request that this motion be heard orally for reasons outlined in letter. (Scanned to Heneghan, J.) received on 15-JUN-2010

Communication to the Court from the Registry dated 09-JUN-2010 re: Motion in writing sent to Presiding Judge for disposition

Letter from Respondent Pharmacience dated 08-JUN-2010 "This letter is in response to the letter sent by counsel for Pfizer/Pharmacia on June 7, 2010. Kindly bring this letter to the attention of Madam Justice Heneghan. In view of the competing arguments of counsel and the relief sought in the motion, we respectfully request that this motion be heard orally than in writing." received on 08-JUN-2010

Letter from Applicant dated 07-JUN-2010 in response to the June 4 letter form Pharmacience's counsel. received on 07-JUN-2010

Letter from Respondent (Pharmascience Inc.) dated 04-JUN-2010 This letter is regarding the written representations in reply to the responding motion record of Pharmascience Inc., and Pharmascience Inc.'s objection to that reply and their reasons for doing so. The letter also contains case law, and a direction from the Federal Court of Appeal. received on 04-JUN-2010

Covering letter from Plaintiffs dated 03-JUN-2010 concerning Doc. Nos. 36 37 placed on file on 03-JUN-2010

Solicitor's certificate of service on behalf of the Applicants confirming service of Reply Representations, Doc.# 36 upon Respondents by telecopier on 03-JUN-2010 filed on 03-JUN-2010

Reply Representations on behalf of the Applicants in response to the opposing submissions doc. No. 34 to the Motion in writing Filed on 03-JUN-2010

Solicitor's certificate of service on behalf of Carol Hitchman confirming service of Book of Authority and document 34 upon Pfizer Canada Inc. and the Minister of Health by Overnight courier on 27-MAY-2010 filed on 28-MAY-2010

Book of Authorities consisting of 1 volume(s) on behalf of Respondent (Pharmascience Inc.) received on 28-MAY-2010

Motion Record in response to Motion Doc. No. 28 containing the following original document(s): 32 33 Number of copies received: 3 on behalf of Respondent (Pharmascience Inc.) filed on 28-MAY-2010

Affidavit of Sandra O'Donohoe sworn on 27-MAY-2010 contained within a Motion Record on behalf of Respondent (Pharmascience Inc.) in opposition to Motion Doc. No. 28 with Exhibits A-F filed on 28-MAY-2010

Written Representations contained within a Motion Record on behalf of Respondent (Pharmascience Inc.) concerning Motion in writing Doc. No. 28 filed on 28-MAY-2010

Covering letter from Applicant dated 18-MAY-2010 concerning Doc. Nos. 30 31 placed on file on 18-MAY-2010

Solicitor's certificate of service on behalf of Me Kavita Ramamoorthy confirming service of the Applicant's Motion Record, Doc.# 30 upon Respondent PHARMASCIENCE INC. by overnight courrier and on THE MINISTER OF HEALTH by personal service on 18-MAY-2010 filed on 18-MAY-2010

Motion Record containing the following original document(s): 28 29 Number of copies received: 3 on behalf of Applicant filed on 18-MAY-2010

Written Representations contained within a Motion Record on behalf of Applicant concerning Motion Doc. No. 28 filed on 18-MAY-2010

Notice of Motion contained within a Motion Record on behalf of Applicant in writing to be placed before the Court in Ottawa for special directions regarding costs pursuant to Rule 403 of the FCR; for an extension of time pursuant to Rule 8 of the FCR; for costs of this motion; and for such further and other relief as to this Honourable Court may seem just; filed on 18-MAY-2010

Certified French language Translation of Reasons for Judgment and Judgment rendered on 18-DEC-2009 by The Honourable Madam Justice Heneghan filed on 17-MAR-2010 pursuant to s. 20 of the Official Languages Act. Certificate of Translation of Judgment entered in J. & O. Book, volume 1083 page(s) 33 - 33 and copy placed on file.

Letter from Def - Pharmascience dated 16-FEB-2010 in response to the letter sent by counsel for Applicants on Feb 12/10. received on 16-FEB-2010

Communication to the Court from the Registry dated 15-FEB-2010 re: letter of the Applicant requesting that the court issue amended reasons

Letter from Applicant dated 12-FEB-2010 requesting that the Court issue, pursuant to Rule 397(2), amended reasons to change certain references and to remove a sentence highlighted in bold from the decision dated 18-DEC-2009 received on 15-FEB-2010

Copy of Notice of Appeal dated 15-JAN-2010 placed on file on 27-JAN-2010 Original filed on Court File No. A-22-10

Reasons for Judgment and Judgment dated 18-DEC-2009 rendered by The Honourable Madam Justice Heneghan Matter considered with personal appearance The Court's decision is with regard to Judicial Review (s.18) Result: THIS COURT ORDERS AND ADJUDGES that the applicant for an Order for Prohibition in respect of the 1,339,132 Patent is granted with costs to the Applicants. Filed on 18-DEC-2009 copies sent to parties Transmittal Letters placed on file. Final Decision Certificate of Judgment entered in J. & O. Book, volume 1075 page(s) 153 - 153

Letter from Applicant dated 18-DEC-2009 Enquiring as to whether the decision in this matter will issue today as the 24 month deadline will expire this Sunday December 20, 2009. (Letter scanned to the Court Dec. 18/09) received on 18-DEC-2009

Solicitor's certificate of service on behalf of Esther Jeon confirming service of Doc. 24 upon Applicant Respondent Applicants-Pfizer, Pharmacia Atkiebolag, Resp-Minister of Health, former sol by telecopier on 02-OCT-2009 filed on 02-OCT-2009

Notice of change of solicitor on behalf of Respondent - Pharmascience Inc. filed on 02-OCT-2009

Transcript of hearing held at Montréal on 10-SEP-2009 received on 11-SEP-2009 Sent directly to presiding Judge 224 pages (including covering pages).

Transcript of hearing held at Montréal on 09-SEP-2009 received on 10-SEP-2009 Sent directly to presiding Judge 223 pages (including covering pages).

Transcript of hearing held at Montréal on 08-SEP-2009 received on 09-SEP-2009 Sent directly to presiding Judge 252 pages (including covering pages).

Montréal 08-SEP-2009 BEFORE The Honourable Madam Justice Heneghan Language: E Before the Court: Judicial Review Result of Hearing: Matter reserved held in Court Senior Usher: Mr. Yves Bouchard 08-SEP-2009 Mme Marthe Patry-Lambert 09-SEP-2009 Mr. jean Lemieux 10-SEP-2009 Duration per day: 08-SEP-2009 from 09:30 to 04:40 Courtroom : Courtroom 306 - Montréal Court Registrar: Rola Chedid 09-SEP-2009 from 09:30 to 04:40 Courtroom : Courtroom 306 - Montréal Court Registrar: Rola Chedid 10-SEP-2009 from 09:35 to 04:30 Courtroom : Courtroom 306 - Montréal Court Registrar: Rola Chedid Total Duration: 3d Appearances: Mr. Brian Daley 514-847-4764 representing Applicant Ms. Judith Robinson 514-847-4608 representing Applicant Ms. Kavita Ramamoorthy 416-216-4097 representing Applicant Ms. Carol Hitchman 416-777-2270 representing Respondent Pharmascience Ms. Esther Jeon 416-777-2270 representing Respondent Pharmascience Court Reporter: Ms. Teresa Forbes, ASAP reporting services 416-861-8720 08-SEP-2009 Ms. Terasa Forbes, ASAP reporting services 416-861-8720 09-SEP-2009 Ms. Teresa Forbes, ASAP reporting services 416-861-8720 10-SEP-2009 Transcript requested (on an expedited basis) Comments: Daily transcripts requested by the Court Minutes of Hearing entered in Vol. 808 page(s) 184 - 190 Abstract of Hearing placed on file

Lettre du procureur du Ministre de la Santé en date du 04-SEP-2009 le Ministre n'aura pas de représentations durant l'audience à venir reçue le 04-SEP-2009

Index of new cases consisting of 1 volume(s) on behalf of Respondent Pharmascience received on 09-SEP-2009 Sent directly to Presiding Judge

Supplemental Book of Authorities consisting of 1 volume(s) on behalf of Applicant received on 04-SEP-2009 Sent directly to Presiding Judge

Letter from Respondent Pharmascience Inc. dated 04-SEP-2009 to advise the Court that they will ask for leave to rely on one additional case recently made public at the hearing and will bring copies in Court received on 04-SEP-2009

Written directions received from the Court: The Honourable Madam Justice Heneghan dated 04-SEP-2009 directing that (in response to letter from Applicant dated Sept. 3/09: Argument will proceed in the usual fashion. For greater clarity as same seems to be required, this means that the Applicants will proceed first, on all issues, to be followed by the Respondent Pharmascience Inc., to be followed by the Applicants¿ reply. If any reply at all is required by the Respondent on the issues of invalidity, the Court will consider any request in that regard in the course of the hearing. filed on 04-SEP-2009 Confirmed in writing to the party(ies)

Letter from the Respondent Pharmascience dated 03-SEP-2009 clarifying their position re: Pfizer's letter received on 04-SEP-2009

Letter from Pfizer and Pharmacia Aktiebolag dated 03-SEP-2009 requesting a case management conference on an urgent basis to discuss the Respondent's request for a reversal in the order of the trial arguments received on 04-SEP-2009

Letter from Resp - Pharmascience Inc dated 02-SEP-2009 asking for leave to rely on one additional case; also requesting Court's allowance for Pharmascience to argue its case on validity in chief... received on 02-SEP-2009

Letter from Applicant dated 17-AUG-2009 requesting projection screen,table et bookshelves for the hearing scheduled September 8, 2009 received on 17-AUG-2009

Letter sent by Registry on 13-JUL-2009 to ASAP Reporting Services requesting the attendance of a stenographer in Montreal on Sept. 8-11, 2009 Copy placed on file.

Book of Authorities consisting of 2 volume(s) on behalf of the Respondent (Pharmascience) - one copy rec'd and sent to MTL received on 30-JUN-2009

Covering letter from Applicant dated 29-JUN-2009 concerning Doc. Nos. 17 18 19 placed on file on 29-JUN-2009

Book of Authorities consisting of 2 volume(s) on behalf of Applicant received on 29-JUN-2009

Solicitor's certificate of service on behalf of Laetitia Caporicci confirming service of doc #19 upon Respondent Pharmascience Inc. by email (on consent) on 29-JUN-2009 confirming service doc #19 upon Respondent Minister by email (on consent) on 29-JUN-2009 filed on 29-JUN-2009

Solicitor's certificate of service on behalf of Laetitia Caporicci confirming service of doc #18 upon Respondent Pharmascience Inc. by personal service on 14-APR-2009 confirming service doc #18 upon Respondent Minister by personal service on 14-APR-2009 filed on 29-JUN-2009

Solicitor's certificate of service on behalf of Laetitia Caporicci confirming service of doc #17 upon Respondent Pharmascience Inc. by courier on 03-APR-2009 confirming service doc #17 upon Respondent Minister by courier on 03-APR-2009 filed on 29-JUN-2009

Memorandum of Fact and Law (VOL II - VALIDITY) on behalf of Applicant filed on 29-JUN-2009 1 judges' copies stored in Ottawa

Memorandum of Fact and Law (VOL I - INFRINGEMENT) on behalf of Applicant filed on 29-JUN-2009 1 judges' copies stored in Ottawa

Applicant's Record (Vols 1-14) Number of copies received/prepared: 3 on behalf of Applicant filed on 29-JUN-2009

Solicitor's certificate of service on behalf of Carol Hitchman confirming service of doc 15 upon all parties by telecopier on 29-JUN-2009 filed on 29-JUN-2009

Memorandum of fact and law on behalf of Respondent (Pharmascience) filed on 29-JUN-2009

Oral directions received from the Court: Kevin Aalto, Prothonotary dated 11-JUN-2009 directing that The amendments to the February 10, 2009 Scheduling Order outlined in the Applicant's letter dated May 28, 2009 are granted as requested. 1. The Court grants leave to the Applicant's to file their Invalidity Memorandum by June 29, 2009. 2. The Court grants leave to Pharmascience, Respondent, to file their Infringement Memorandum by June 29, 2009. 3. The Court grants leave for the total length of each Party's Memorandum (Volumes I and II) not to exceed 47 pages. placed on file on 11-JUN-2009 Confirmed in writing to the party(ies)

Letter from Applicant dated 28-MAY-2009 they hereby request the Scheduling Order dated Feb 10, 2009 be amended. In addition, they also request that paragraph 6 of Protonotary Aalto's Order dated May 7, 2008 be amended and they also request that this letter be treated as a motion to amend the schedule of the pre-hearing steps. filed on 28-MAY-2009

Letter from Respondent, Pharmascience dated 17-APR-2009 addressing the issue re: length of the factum in this application (cc'd to all parties) received on 17-APR-2009

Notice of Change of Address on behalf of Applicant received on 14-MAY-2009

Memorandum to file from Yoginder Gulia dated 14-APR-2009 that Respondent(Pharmascience) has filed memorandum of fact and law today on Infringement(Vol.1) consisting of 40 pages. Court order has allowed only 40 pages for both volumes. Court directions may be needed while accepting Vol.2 of it. placed on file.

Solicitor's certificate of service on behalf of Carol Hitchman confirming service of doc 12 and Authorities upon Applicant and Respondent(Minister of Health) by courier on 14-APR-2009 filed on 14-APR-2009

Book of Authorities consisting of 2 volume(s) on behalf of Respondent(Pharmascience) received on 14-APR-2009

Memorandum of fact and law on behalf of Respondent(Pharmascience) filed on 14-APR-2009 1 judges' copies retained by the local office

Letter from Applicant dated 08-APR-2009 further to recent correspondence between parties and a draft order submitted to the Court received on 08-APR-2009

Letter from Respondent, Pharmascience dated 06-APR-2009 in response to the Applicant's letter of 3-APR-2009 (cc'd to A's counsel) received on 06-APR-2009

Letter from Applicant dated 03-APR-2009 Asking for this letter to be directed to Prothonotary Aalto and requesting that the current Order(scheduling) be "varied slightly so that paragraphs 1(c), (d) and (e) are amended to replace the word "file" with the word "serve". Paragraph (f) would be then be added to the order to read "Both parties are to file their respective Application Records by Friday, June 19, 2009."" received on 03-APR-2009

Order dated 10-FEB-2009 rendered by Kevin Aalto, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from Respondent, Pharmasceience dated 29-JAN-2009 Result: the schedule for the reamining pre-hearing steps shall be amended as follows: a)...b)...c) Applicants to file Application Record, except for Memorandum of Fact and Law, by April, 3 2009; d) Applicants to file Volume I of their Memorandum of Fact and Law (on infringement) and Pharmascience to file Volume I of its Memorandum of Fact and Law (on invalidity) by April 10, 2009; e) Pharmascience to file Volume II of its Memorandum of Fact and Law (on infringement) and Applicants to file Volume II of their Memorandum (on validity) by June 19, 2009... 2. The respondents Pharmascience may file the affidavit of Dr. George Spaetyh which adopts the affidavit of Dr. Podos. Filed on 10-FEB-2009 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1046 page(s) 451 - 453 Interlocutory Decision

Order (time and place) dated 12-FEB-2009 rendered by Chief Justice Lutfy and signed by Judicial Administrator fixing Judicial Review (s.18) to be heard at Special Sitting in Montréal on 08-SEP-2009 to begin at 09:30 duration: 4d language: E Filed on 13-FEB-2009 cc's sent to parties entered in J. & O. Book, volume 1046 page(s) 290 - 290 Transmittal letters placed on file

Letter from Respondent dated 28-JAN-2009 Re: requesting an extension of time received on 29-JAN-2009

Requisition for hearing - Application from Applicant with proof of service upon Respondent on 17-DEC-2008 filed on 17-DEC-2008 Tariff Application or appeal - $50.00

Oral directions received from the Court: Kevin Aalto, Prothonotary dated 08-DEC-2008 directing that "The Applicants have written to the Court requesting an extension, on consent, to the schedule established in the order of May 7, 2008. By way of this direction the schedule is amended as follows: 1. Cross-examinations to be completed by December 16, 2008; 2. Applicants to file a Requisition for Hearing by December 17, 2008; 3. Applicants to file their Application Record, excluding the memorandum of fact and law, on or before February 20, 2009; 4. Applicants to file Volume I of their memorandum of fact and law (on infringement) and Pharmascience to file Volume I of its memorandum of fact and law (on invalidity) on or before February 27, 2009; 5. Pharmascience to file Volume II of its memorandum of fact and law (on infringement) and the Applicants to file Volume II of their memorandum of fact and law (on validity) on or before May 8, 2009." placed on file on 09-DEC-2008 Confirmed in writing to the party(ies)

Letter from Applicant dated 01-DEC-2008 advising the Court that they had to reschedule cross-examinations due to illnesses of an expert and the spouse of another expert and this letter is to be treated as a motion to amend the schedule of the pre-hearing steps and that the parties be relieved from filing motion materials with the Court (cc'd to all parties) received on 01-DEC-2008

Letter from Respondent dated 10-OCT-2008 informing the Court of the change of counsel for the Respondent received on 10-OCT-2008

Order dated 07-MAY-2008 rendered by Kevin Aalto, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from Respondent dated 02-MAY-2008 Result: "1. If the Court decides that Pharmascience's allegation of invalidity of one or more of Claims 12, 19, 31, 37 or 38 is not justified, the Court shall prohibit the Minister of Health from issuing a Notice of Compliance to Pharmascience in respect of its 50 micorgram/ml ophthalmic solution of lantanoprost until after the expiry of the '132 Patent. 2. If the Court decides that Pharmascience's allegation of invalidity of each and every one of Claims 9, 19, 31, 37 or 38 of the '132 Patent is justified, the Court shall dismiss the Application and confirm that the Minister of Health is not prohibited, by reason of the Patented Medicines... Regulations from issuing a Notice of Compliance to Pharmascience... 3. This Order is without prejudice to the Applicants' right to assert infringement, or to Pharmascience's right to assert invalidity, of any claim of the '132 Patent in a future action. 4. This Order is without prejudice to the Applicants' right to assert any c claim of the '132 Patent in other proceedings against other parties under the Patented Medicines...Regulations. 5. The parties shall respect the following schedule for the completion of the next steps in this proceeding: a. Applicants to serve their evidence on infringement and Pharmascience to serve its evidence on invalidity by Friday, May 2, 2008, and both Applicants and Pharmascience to dispense with filing of evidence with the Court until filing of their respective Application Records; b. Pharmascience to serve its evidence on infringement and Applicants to serve their evidence on validity by Friday, August 29,2 008, and both Applicants and Pharmascience to dispense with filing of evidence with the Court until filing of their respective Application Records; c. Cross-examinations on affidavit to be completed by Friday, November 28, 2008; d. Applicants to file a Requisition for Hearing by Tuesday, December 2, 2008 e. Applicants to file Application Record, except for memorandum of fact and law, by Friday, February 6, 2009; f. Applicants to file Volume I of their Memorandum of Fact and Law (on infringement) and Pharmascience to file Volume I of its Memorandum of Fact and Law (on invalidity) by Friday, February 13, 2009; and g. Pharmascience to file Volume II of its Memorandum of Fact and Law (on infringement) and Applicants to file Volume II of their Memorandum of Fact a Law (on validity) by Friday, April 24, 2009. 6. The total length of each party's Memorandum (Volumes I and II) shall not exceed 40 pages. 7. In the event that any of the times stipulated in the timetable in paragraph 5 herein require amendment, such amendment shall be sought by the party by arranging a case conference with the Court which will issue the appropriate directions without the party having to bring a motion to amend. 8. No party shall bring any motion in this proceeding unless and until a case conference has been convened to review the issue(s( which will be the subject of the proposed motion. 9. Any party, at any time, may request a case conference with the Court to review any issue that arises in the conduct of this Application. 10. There shalla be no costs in respect of this Order." Filed on 08-MAY-2008 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1022 page(s) 338 - 342 Interlocutory Decision

Letter from Pharmascience Inc. dated 02-MAY-2008 pursuant to the Order of Prothonotary Aalto dated April 25, 2008[...]upon consent, the parties respectufully request to dispense with the filing of the evidence until the filing of their respective Application Records. [...]attached draft Amended Order and signed consent of all parties[...] Kindly ask that the Court issue a direction...or set down a case conference received on 02-MAY-2008

Order dated 25-APR-2008 rendered by Kevin Aalto, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Stated Case Result: The parties shall respect the following schedule: 1. Applicant's to file their evidence on infringment by May 2/08 2. Pharmascience to file its evidence on infringment and applicants to file their evidence on validity by Aug 29, 2008 3. Cross examinatinos to be completed by Nov 28, 2008 4. Applicant's to file req. for hearing by Dec 2/08 5. Applicant's to file application record, except for memo of law, by Feb 6/09 6. Applicant's to file vol 1 of Memo of law and Pharmascience to file vol 1 of its memo of law by Feb 13, 2009 7.Pharmascience to file vol 11 of its memo of law and applicant's to file vol. 2 of its memo of law by April 24/09 8. The total length of each party's Memoradum (vol 1 and 2) shall not exceed 40 pages 9. No party shall bring and motion in this proceeding unless a case conference has been convened to review the issues Filed on 25-APR-2008 entered in J. & O. Book, volume 1020 page(s) 84 - 87 Interlocutory Decision

Copy of a Letter from Respondent Pharmascience Inc. to Counsel of Applicants dated 08-APR-2008 asking to provide them with the correspondence date 18-Feb-2008 regarding the Court's request to provide the electronic version of the draft order, and correspondence dated 19-Mar-2008 and 27-Mar-2008, each regarding the status of the draft order. They also asked to be copied on all correspondence between the firm and the Court in the future. received on 08-APR-2008

Order dated 07-APR-2008 rendered by Chief Justice Lutfy Matter considered without personal appearance The Court's decision is with regard to Letter from Applicant dated 08-FEB-2008 re: request to make the proceeding specially managed. Result: IT IS ORDERED pursuant to Rule 383 that Prothonotary Kevin Aalto is designated as Case Management Judge in this matter. Filed on 08-APR-2008 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1018 page(s) 98 - 98 Interlocutory Decision

Letter from Plaintiff dated 02-APR-2008 refering to their letters of february 8,2008 and 18, inquiring on the status of their request for an order to make the case specially- managed; received on 03-APR-2008

Letter from Applicant dated 08-FEB-2008 "pursuant to the recent "Practice Direction - NOC Proceedings" issued by the Chief Justice, the parties have agreed to seek an order to make this proceeding specially-managed (...) " received on 08-FEB-2008

Notice of appearance on behalf of Respondent, The Minister of Health with proof of service upon Applicants and Respondent, Pharmascience Inc. on 03-JAN-2008 filed on 04-JAN-2008

Covering letter from Defendant Pharmascience Inc. dated 02-JAN-2008 concerning Doc. Nos. 3 4 placed on file on 03-JAN-2008

Solicitor's certificate of service on behalf of Greg Beach, Solicitor for the Respondent Pharmascience Inc., confirming service of of Notice of Appearance (doc. 3) upon Applicant and Defendent Minister of Health by telecopier on 02-JAN-2008 filed on 03-JAN-2008

Notice of appearance on behalf of Respondent Pharmascience Inc. filed on 03-JAN-2008

Service copy of Notice of Application (doc. 1) with proof of service upon Defendant Pharmascience Inc. on 20-DEC-2007 and upon Defendant the Minister of Health (Deputy Attorney General of Canada) on 21-DEC-2007 filed on 27-DEC-2007

Covering letter from Applicants dated 20-DEC-2007 concerning Doc. No. 1 placed on file on 20-DEC-2007

Notice of application and 2 copies with regard to Patented Medicines (Notice of Compliance) dated November 2, 2007 filed on 20-DEC-2007 Tariff fee of $50.00 received: yes